Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 3
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
Designing phase II clinical trials in Friedreich ataxia.
Rodden LN, Lynch DR. Rodden LN, et al. Expert Opin Emerg Drugs. 2021 Dec;26(4):415-423. doi: 10.1080/14728214.2021.1998452. Epub 2021 Dec 22. Expert Opin Emerg Drugs. 2021. PMID: 34693848 Review.
Friedreich ataxia: clinical features and new developments.
Keita M, McIntyre K, Rodden LN, Schadt K, Lynch DR. Keita M, et al. Among authors: rodden ln. Neurodegener Dis Manag. 2022 Jun 29. doi: 10.2217/nmt-2022-0011. Online ahead of print. Neurodegener Dis Manag. 2022. PMID: 35766110 Review.
Cerebellar Pathology in an Inducible Mouse Model of Friedreich Ataxia.
Mercado-Ayón E, Warren N, Halawani S, Rodden LN, Ngaba L, Dong YN, Chang JC, Fonck C, Mavilio F, Lynch DR, Lin H. Mercado-Ayón E, et al. Among authors: rodden ln. Front Neurosci. 2022 Mar 24;16:819569. doi: 10.3389/fnins.2022.819569. eCollection 2022. Front Neurosci. 2022. PMID: 35401081 Free PMC article.